These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26117277)

  • 1. Real-World Vinflunine Outcomes in Bladder Cancer in a Single-Institution Study: Moving Beyond Clinical Trials.
    Moriceau G; Vallard A; Rivoirard R; Méry B; Espenel S; Langrand-Escure J; Ben Mrad M; Wang G; Diao P; Pacaut C; Guillot A; Collard O; Fournel P; Magné N
    Clin Genitourin Cancer; 2015 Dec; 13(6):588-92. PubMed ID: 26117277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).
    Passalacqua R; Lazzarelli S; Donini M; Montironi R; Tambaro R; De Giorgi U; Pignata S; Palumbo R; Ceresoli GL; Del Conte G; Tonini G; Morelli F; Nolè F; Panni S; Rondini E; Guida A; Zucali PA; Doni L; Iezzi E; Caminiti C
    BMC Cancer; 2017 Jul; 17(1):493. PubMed ID: 28724419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series.
    Palumbo R; Licata L; Sottotetti F; Tagliaferri B; Pozzi E; Teragni C; Quaquarini E; Bernardo A
    Oncol Res Treat; 2018; 41(1-2):8-13. PubMed ID: 29402855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland.
    Hussain SA; Ansari J; Huddart R; Power DG; Lyons J; Wylie J; Vilarino-Varlela M; Elander NO; McMenemin R; Pickering LM; Faust G; Chauhan S; Jackson RJ
    Int J Oncol; 2017 Mar; 50(3):768-772. PubMed ID: 28098864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy.
    Bellmunt J; Fougeray R; Rosenberg JE; von der Maase H; Schutz FA; Salhi Y; Culine S; Choueiri TK
    Ann Oncol; 2013 Jun; 24(6):1466-72. PubMed ID: 23419284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
    Castellano D; Puente J; de Velasco G; Chirivella I; López-Criado P; Mohedano N; Fernández O; García-Carbonero I; González MB; Grande E
    BMC Cancer; 2014 Oct; 14():779. PubMed ID: 25342282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study.
    Abdel-Malek R; Shohdy KS; Abbas N; Ismail M; Hamada E; Abdel-Kader Y
    Curr Drug Saf; 2019; 14(1):31-36. PubMed ID: 30277164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.
    Pistamaltzian N; Tzannis K; Pissanidou V; Peroukidis S; Milaki G; Karavasilis V; Mitsogiannis I; Varkarakis I; Papatsoris A; Dellis A; Adamakis I; Stravodimos K; Molyva D; Athanasiadis I; Androulakis N; Andreadis C; Kalofonos C; Mitropoulos D; Deliveliotis C; Constantinides C; Dimopoulos MA; Bamias A
    Anticancer Drugs; 2016 Jan; 27(1):48-53. PubMed ID: 26421462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinflunine.
    Prescrire Int; 2011 Jan; 20(112):11-3. PubMed ID: 21462785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study.
    Vaughn DJ; Srinivas S; Stadler WM; Pili R; Petrylak D; Sternberg CN; Smith DC; Ringuette S; de Wit E; Pautret V; George C
    Cancer; 2009 Sep; 115(18):4110-7. PubMed ID: 19536904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.
    Retz M; de Geeter P; Goebell PJ; Matz U; de Schultz W; Hegele A
    BMC Cancer; 2015 Jun; 15():455. PubMed ID: 26040470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.
    Bellmunt J; Théodore C; Demkov T; Komyakov B; Sengelov L; Daugaard G; Caty A; Carles J; Jagiello-Gruszfeld A; Karyakin O; Delgado FM; Hurteloup P; Winquist E; Morsli N; Salhi Y; Culine S; von der Maase H
    J Clin Oncol; 2009 Sep; 27(27):4454-61. PubMed ID: 19687335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective analysis of German routine data.
    Hegele A; Goebell P; Matz U; Neuhaus T
    Urol Int; 2014; 92(2):174-9. PubMed ID: 24334998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting.
    Guglieri-López B; Pérez-Pitarch A; Porta-Oltra B; Ferriols-Lisart F; Climente-Martí M; Alós-Almiñana M
    Anticancer Drugs; 2015 Sep; 26(8):860-5. PubMed ID: 25919319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
    Bellmunt J; Kerst JM; Vázquez F; Morales-Barrera R; Grande E; Medina A; González Graguera MB; Rubio G; Anido U; Fernández Calvo O; González-Billalabeitia E; Van den Eertwegh AJM; Pujol E; Perez-Gracia JL; González Larriba JL; Collado R; Los M; Maciá S; De Wit R;
    Ann Oncol; 2017 Jul; 28(7):1517-1522. PubMed ID: 28419193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
    Krajewski KM; Fougeray R; Bellmunt J; Pons F; Schutz FA; Rosenberg JE; Salhi Y; Choueiri TK
    Eur J Cancer; 2012 Jul; 48(10):1495-502. PubMed ID: 22176867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.
    De Luca R; Profita G; Vella M; Cicero G
    Oncology; 2019; 97(6):341-347. PubMed ID: 31461721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vinflunine: still an option for patients with advanced urothelial carcinoma following immune-checkpoint inhibitors?].
    Banna GL; Rundo F; Lipari H; Di Quattro R; Urzia V; Libra M; Malatino L
    Recenti Prog Med; 2019 Dec; 110(12):615-618. PubMed ID: 31909764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Clinical Trials to the Front Line: Vinflunine for Treatment of Urothelial Cell Carcinoma at the National Cancer Institute of Naples.
    Facchini G; Della Pepa C; Cavaliere C; Cecere SC; Di Napoli M; D'Aniello C; Crispo A; Iovane G; Maiolino P; Tramontano T; Piscitelli R; Pisconti S; Montella M; Berretta M; Sorrentino D; Perdonà S; Pignata S
    Front Pharmacol; 2016; 7():110. PubMed ID: 27199753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinflunine.
    Frampton JE; Moen MD
    Drugs; 2010 Jul; 70(10):1283-93. PubMed ID: 20568834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.